76 min listen
Episode 50
FromBiotech Hangout
ratings:
Length:
67 minutes
Released:
Mar 3, 2023
Format:
Podcast episode
Description
This week, Paul Hastings, Chief Executive Officer and President of Nkarta Therapeutics and Chair of the Biotechnology Innovation Organization (BIO), joins Biotech Hangout hosts Daphne Zohar, Josh Schimmer, Rob Perez and Dawn Bell. The group discusses the latest biotech industry consolidations and dissolutions and Big Pharma’s looming patent cliff. They touch on controversies surrounding Vertex’s latest drug pricing, the abortion pill ban and pending implications for the FDA, industry diversity and Vivek Ramaswamy’s resignation from Roivant’s Board of Directors as he prepares to pursue his U.S. presidential campaign.
Released:
Mar 3, 2023
Format:
Podcast episode
Titles in the series (69)
Episode 32 by Biotech Hangout